FibroBiologics (FBLG) Interest Coverage Ratio (2023 - 2026)

FibroBiologics (FBLG) has reported Interest Coverage Ratio for 4 consecutive years, with 576.14 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Interest Coverage Ratio changed N/A year-over-year to 576.14; the trailing twelve-month figure through Jun 2026 stood at 77.81 (up 94.68% YoY), and the FY2025 full-year result was 81.61, up 88.12% from the prior year.
• Interest Coverage Ratio grew to 576.14 in Q2 2026 per FBLG's latest filing, from 1267.0 in the prior quarter.
• Across five years, Interest Coverage Ratio topped out at 12.7 in Q4 2025 and bottomed at 2480.0 in Q4 2023.
• Historically, Interest Coverage Ratio has averaged 735.83 across 4 years, with a median of 631.73 in 2024.
• The sharpest annual moves came in 2024 and 2025: Interest Coverage Ratio slumped 5040.73% in 2024, then jumped 97.95% in 2025.
• Over 4 years, Interest Coverage Ratio stood at 2480.0 in 2023, then soared by 75.05% to 618.67 in 2024, then surged by 97.95% to 12.7 in 2025, then tumbled by 4437.96% to 576.14 in 2026.
• According to Business Quant data, Interest Coverage Ratio over the past three periods registered 576.14, 1267.0, and 12.7 for Q2 2026, Q1 2026, and Q4 2025 respectively.